Drug-Coated Balloon for Diffuse Coronary Artery Disease
Authors:
- Kazumasa IkedaKIKazumasa Ikeda
- Kazuya TakiharaKTKazuya Takihara
- Kosei TeradaKTKosei Terada
Open Access
- 6 October 2026
- journal article
- Published by Elsevier in JACC: Asia
- Vol. 6 (10) , 2290-2292
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- Physiological Patterns of Coronary Artery Disease and Drug-Coated Balloon PerformanceJACC: Asia, 2026
- Coronary Atherosclerosis Phenotypes in Focal and Diffuse DiseaseJACC: Cardiovascular Imaging, 2023
- Prognostic Implications of Quantitative Flow Ratio–Derived Physiological 2-Dimensional Residual Disease Patterns After StentingJACC: Cardiovascular Interventions, 2022
- 2021 ACC/AHA/SCAI Guideline for Coronary Artery RevascularizationJACC, 2022
- Physiological Distribution and Local Severity of Coronary Artery Disease and Outcomes After Percutaneous Coronary InterventionJACC: Cardiovascular Interventions, 2021
- Feasibility of Quantitative Flow Ratio–Derived Pullback Pressure Gradient Index and Its Impact on Diagnostic PerformanceJACC: Cardiovascular Interventions, 2021
- Measurement of Hyperemic Pullback Pressure Gradients to Characterize Patterns of Coronary AtherosclerosisJACC, 2019
- The Role of Drug-Eluting Balloons Alone or in Combination With Drug-Eluting Stents in the Treatment of De Novo Diffuse Coronary DiseaseJACC: Cardiovascular Interventions, 2013
- Incidence and predictors of coronary stent thrombosis: Evidence from an international collaborative meta-analysis including 30 studies, 221,066 patients, and 4276 thrombosesInternational Journal of Cardiology, 2013
- Predictors of Restenosis After Placement of Drug-Eluting Stents in One or More Coronary ArteriesThe American Journal of Cardiology, 2006